Piex Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Piex Pharmaceutical Import Records from India — 2 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Piex — Pharmaceutical Importer Profile (2026) | 2 Products, $1.4M Trade | TransData Nexus

Piex

Pharmaceutical Importer · France · Vitamins & Supplements Focus · $1.4M Total Trade · DGFT Verified

Piex is a pharmaceutical importer based in France with a total trade value of $1.4M across 2 products in 2 therapeutic categories. Based on 33 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Piex sources from 24 verified Indian suppliers, with Impact Healthcare Private Limited accounting for 22.8% of imports.

Piex — Import Portfolio & Supplier Network

Piex import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Piex?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Impact Healthcare Private Limited	$5.0M	802	22.8%
Croient Pharma Private Limited	$4.7M	691	21.3%
Til Healthcare Private Limited	$4.6M

What Formulations Does Piex Import?

Formulation	Value	Ships
Fevastin i.v. infusion - 100ML	$414.1K	12
Pharmaceuticals- astymin sn-200ML (purecrystalline amino acids iv infusion withxylitol)	$376.0K	8
Pharmaceuticals fevastin i v 100ML paracetamol i v	$359.7K	12
Tab.adione (doxylamine succinate &	$322.1K	8
Astymin sn i.v. infusion - 200ML(pure	$300.0K	6
Pharmaceuticals- fevastin i.v.	$227.0K	6
Pharmaceuticals- fevastin i.v-100ML (paracetamol i.v.infusion)	$225.2K	6
Benzathine benzylpenicilline 2.4miu INJ	$204.0K	6
Astymin sn i.v. infusion - 200ML	$195.9K	4
Pharmaceuticals- fevastin i.v -100ML (paracetamol i.v infusion)	$171.2K	9
Multivitamin injection (Each 10 ML	$158.1K	5
Pharmaceuticals- astymin sn i.v.	$150.0K	3
Pregasafe 75MG (3x10s) piex -fwa (9750 nos sample purpose)	$150.0K	3
Crosscal tablets (calcium 500 MG and	$137.3K	4
Myoxeril (cyclobenzaprine hydrochloride10 MG)	$133.1K	3

Piex imports 1,583 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Calcium	Vitamins & Supplements	$1.1M	21	0.1%	17
2	Benzylpenicillin	Advanced Antibiotics	$366.8K	12	9.5%	3

Piex imports 2 pharmaceutical products across 2 categories into France totaling $1.4M.

Piex — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Piex, officially known as Société Pharmaceutique d’Import-Export, is a French company specializing in the distribution of pharmaceutical and healthcare products. Established in 1979 by Robert Jamain, Piex has evolved into a significant player in the pharmaceutical sector, focusing primarily on the African market. The company's headquarters are located at 3-7 Avenue du Cap Horn, Les Ulis, France.

In July 2017, Piex underwent a strategic acquisition led by LBO France, in partnership with AfricInvest Europe, BNP Paribas Développement, BPI, and Trocadéro Capital Partners. This acquisition aimed to enhance Piex's capabilities in distributing genuine medicines and parapharmaceuticals across Africa, the Middle East, and Asia.

Piex operates as an independent distributor, serving as a crucial link between pharmaceutical manufacturers and healthcare providers, particularly in Sub-Saharan Africa. The company offers a comprehensive range of services, including marketing, regulatory affairs, and logistics, ensuring efficient access to quality health and wellness products.

2Distribution Network

Piex's distribution network is strategically designed to serve a wide array of markets, with a primary focus on Sub-Saharan Africa. The company manages a substantial inventory, offering over 1,500 product references tailored to meet the diverse needs of the region.

Logistically, Piex operates a network of warehouses equipped to handle a variety of products, including medicines, food supplements, and hygiene products. The company emphasizes compliance with Good Distribution Practices (GDP) and is recognized as an Authorized Economic Operator by French Customs, ensuring secure and efficient logistics operations.

3Industry Role

Within France's pharmaceutical supply chain, Piex functions as a specialized distributor, focusing on the export of pharmaceutical and healthcare products to various international markets, particularly in Africa and Asia. The company's role is pivotal in bridging the gap between manufacturers and end-users, ensuring the availability of quality health products in regions with limited access.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Piex

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Piex's sourcing strategy reveals a high concentration of imports from India, with a total import value of $1.4 million USD across 33 shipments. The top two imported products are Calcium ($1.1 million, 0.1% share) and Benzylpenicillin ($367,000, 9.5% share). This concentration indicates a strategic choice to source specific formulations from India, likely due to cost-effectiveness and product availability.

The shipment data, with 33 entries, suggests a stable and ongoing relationship with Indian suppliers. However, the lack of diversification in sourcing could pose risks related to supply chain disruptions or regulatory changes in India. Diversifying suppliers and products may enhance resilience and mitigate potential risks.

2Supply Chain Resilience

Piex's supply chain resilience is closely tied to its sourcing strategy from India. The company's reliance on a limited number of suppliers for specific formulations may expose it to risks such as supply disruptions or regulatory changes in India. To enhance resilience, Piex could consider diversifying its supplier base and product range, thereby reducing dependency on a single source.

3Strategic Implications

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the Agence Nationale de la Sécurité du Médicament et des Produits de Santé (ANSM). The ANSM is responsible for ensuring the safety, efficacy, and quality of health products available in the French market.

Key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for marketing authorization, importation, and distribution of medicinal products. The marketing authorization pathway for Indian generics involves obtaining a Marketing Authorization (MA) from the ANSM, ensuring compliance with French and European Union standards.

2Import Licensing & GMP

Import licensing requirements in France stipulate that all pharmaceutical products must have a valid Marketing Authorization (MA) issued by the ANSM. Good Manufacturing Practice (GMP) certificates recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S, are mandatory for suppliers. Additionally, wholesale distribution authorization is required for entities involved in the distribution of medicinal products within France.

3Quality & Labeling

Piex — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Piex's focus on importing Calcium and Benzylpenicillin aligns with the therapeutic needs of the African market, where there is a significant demand for essential medicines. The company's strategy to import these specific products suggests a targeted approach to address prevalent health issues in the regions it serves.

2Sourcing Profile

Piex's sourcing strategy emphasizes importing generic drugs from India, particularly in the categories of Vitamins & Supplements and Advanced Antibiotics. This approach leverages India's manufacturing capabilities and cost advantages, ensuring a steady supply of essential medicines to meet the needs of the African market.

3Market Positioning

Based on its product mix, Piex serves the wholesale distribution segment of the French market, focusing on exporting pharmaceutical products to African countries. The company's role is crucial in ensuring the availability of essential medicines and health products in regions with limited access to such resources.

Seller's Guide — How to Become a Supplier to Piex

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Piex, especially those offering products that complement the existing portfolio. Identifying gaps in Piex's current sourcing, such as additional therapeutic categories or formulations, could lead to mutually beneficial partnerships.

2Requirements & Qualifications

Indian exporters aiming to supply Piex and the French market must ensure their products have valid Marketing Authorization from the ANSM. Compliance with recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S, is essential. Additionally, adherence to French labeling requirements, including French language labeling and serialization mandates, is mandatory.

3How to Approach

Indian exporters should initiate contact with Piex by providing detailed product information, including compliance with French regulatory standards. Participating in relevant tenders and aligning with Piex's strategic goals can enhance the partnership potential. Understanding the regulatory filing process and expected timelines for marketing authorization in France is crucial for a successful collaboration.

Frequently Asked Questions — Piex

What products does Piex import from India?

Piex imports 2 pharmaceutical products across 2 categories. Top imports: Calcium ($1.1M), Benzylpenicillin ($366.8K).

Who supplies pharmaceuticals to Piex from India?

Piex sources from 24 verified Indian suppliers. The primary supplier is Impact Healthcare Private Limited (22.8% of imports, $5.0M).

What is Piex's total pharmaceutical import value?

Piex's total pharmaceutical import value from India is $1.4M, based on 33 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Piex focus on?

Piex imports across 2 categories. The largest: Vitamins & Supplements (74.1%), Advanced Antibiotics (25.9%).

Get Full Piex Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.